Targeting Cancers With CAR T and NK CellsByJan Davidson, MD, PhDSeptember 23rd 2021Jan Davidson, MD, PhD, chief medical officer, Wugen, discussed the company’s future plans and research.
Optimizing Manufacturing of NK Cell and CAR T Therapies for Cancer TreatmentByJan Davidson, MD, PhDSeptember 14th 2021Jan Davidson, MD, PhD, chief medical officer, Wugen, discussed the company’s cell therapy platforms.